Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S RAPAPORT

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|January 24, 2025
An essential role for TASL in mouse autoimmune pathogenesis and Toll-like receptor signalingLaura Lau, Taryn A Cariaga, Abraham B Chang, et al.
Nature|February 11, 2014
L-Myc expression by dendritic cells is required for optimal T-cell primingWumesh KC, Ansuman T Satpathy, Aaron S Rapaport, et al.
Cell|April 18, 2020
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerLei Zhang, Ziyi Li, Katarzyna M Skrzypczynska, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Nature|November 1, 2019
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunityJude Canon, Karen Rex, Anne Y Saiki, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|January 24, 2025
An essential role for TASL in mouse autoimmune pathogenesis and Toll-like receptor signalingLaura Lau, Taryn A Cariaga, Abraham B Chang, et al.
Nature|February 11, 2014
L-Myc expression by dendritic cells is required for optimal T-cell primingWumesh KC, Ansuman T Satpathy, Aaron S Rapaport, et al.
Cell|April 18, 2020
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerLei Zhang, Ziyi Li, Katarzyna M Skrzypczynska, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
Nature|November 1, 2019
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunityJude Canon, Karen Rex, Anne Y Saiki, et al.
Pageof 3